Topical 0.4% Ketorolac and Vitreoretinal Surgery

Phase 2

Completed

• Conditions: Surgery
• Interventions: Drug: Ketorolac

• Registration Number: NCT00576329
• Lead Sponsor: Emory University

Brief Summary

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Detailed Description

Other outcomes will be to assess postoperative pain and inflammation and visual acuity.

Study Timeline

• Study Start: 2006-11
• Study Completion: 2007-10
• Study First Submitted: 2007-12-17
• Study First Submitted QC: 2007-12-17
• Study First Posted: 2007-12-19
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-12
• Last Update Posted: 2014-05-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

• Age of 18, routine elective vitrectomy

Exclusion Criteria

• history of trauma, uveitis, prior intraocular surgery within 3 months, requirement of mechanical pupil dilation, prior inclusion of other eye

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
A	Ketorolac	-
B	Ketorolac	-

Primary Outcome Measures

Name	Time	Method
Change in pupil size during vitreoretinal surgery	Surgery

Secondary Outcome Measures

Name	Time	Method
Postoperative pain and inflammation	1 day

Trial Locations

Locations (1)

Emory Eye Clinic; 🇺🇸 Atlanta, Georgia, United States